The operational gap value-based care can no longer ignore

A pair of regulatory changes from the Centers for Medicare & Medicaid Services are resetting what it means to succeed under value-based care. Together, they reinforce a broader shift toward operational precision, which is increasingly shaping reimbursement and leaving organizations with less room to recover from failures after the fact.

For many organizations, that means the assumptions that sustained earlier versions of value-based care are beginning to break down. Unless they close the gap between how they deliver care and how precisely their operations can demonstrate it, the flexibility they once relied on to absorb breakdowns will continue to disappear, putting reimbursement at increasing risk.

That gap often sits inside the unglamorous infrastructure of health care operations, where a breakdown in documentation, coding or claim submission may go undetected until it reaches the reimbursement process. For years, the delay between delivering care and reconciling the quality metrics attached to it allowed many of those weaknesses to be corrected before they became financially consequential.

Value-based care reimbursement has never been a simple bill-and-collect transaction. It flows on the back end, through quality metrics reconciled well after care is delivered. That lag leaves organizations not knowing for weeks or months whether their underlying operations are sound.

Back-end flexibility used to keep many organizations anchored to metrics they already understood: accounts receivable aging, net collection rate and the traditional fee-for-service measures still treated as the gold standard in most finance departments. But those numbers say little about whether a value-based contract is actually performing. The metrics that do predict performance sit downstream of a process most organizations have never built with enough precision: getting a clean claim out the door to the correct payer on time.

Buried between the metrics organizations trust and the ones that actually govern reimbursement is a people-and-process failure that has sat quietly inside value-based care since the model emerged. It no longer does.

CMS made it audible in January 2026, when it closed the mechanism that let that gap go unpriced. Providers could once treat claim submission as an early step in a longer reconciliation process, cleaning up quality documentation later through supplemental data submissions. That opportunity has narrowed considerably: A claim must now be on file before CMS will link any quality data to it, so gaps in documentation or timeliness affect reimbursement immediately instead of surfacing months later.

The proposed CY 2027 fee schedule, released by CMS in June, extends the same logic by pruning quality measures it says no longer provide value and tightening specialty-specific reporting, with accountable care organizations pushed further into two-sided risk. Neither change is a compliance update on its own, but taken together, they describe a regulator narrowing the room organizations have to operate loosely and still get paid.

What this means for providers is that their revenue cycles, which have long been treated as a necessary administrative function, are now increasingly bleeding into a strategic one. CMS’s recent changes are making the distinction between the two increasingly difficult to sustain.

A breakdown anywhere in the claim-filing sequence now shows up directly in reimbursement, whether it’s in the clinical note from providers, the diagnostic code from coders or the specialty code that drives quality scoring. A rejected claim starts the billing process over again until it clears.

Long treated as an administrative task, claim filing has historically been overlooked by health care leadership. But with these changes from CMS, the claim rejection rate is now an essential indicator of whether the sequence is working.

The precision that determines whether a claim clears also determines whether an organization can prove what value-based care actually pays for. Reducing hospital readmissions lowers the cost of a patient’s care, and value-based contracts share those savings between payer and provider, but only once the reduction is proven through the same documentation and coding chain that produces a clean claim. Getting a claim out the door and proving clinical value run through the same operational chain.

Health care leaders should take a different lesson from this than the instinct to add more reporting infrastructure. Reporting was never the constraint.

Success depends on whether the operational sequence behind that reporting, from clinical encounter to coded, submitted, accepted claim, holds together consistently enough to be trusted. That doesn’t require a new dashboard. It requires leadership attention on the operational chain itself, the same rigor already expected of clinical care, applied now to the process that proves clinical care worked.

CMS’s 2026 changes are not a final destination. The January claim-on-file requirement and the proposed CY 2027 fee schedule point in the same direction, and nothing in either suggests that direction is settling.

Organizations that treat this year’s changes as a compliance exercise to complete and move past will find themselves recalibrating again the next time CMS narrows what counts. Those that treat operational discipline as a standing requirement will find the standard already at their door.

Matt Wallace is the practice leader of LBMC’s Healthcare Advisory Services in Nashville, Tennessee.